A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Clinical trial NCT01787552 · COMPLETED
Trial details
- NCT number
- NCT01787552
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-08
- Primary completion
- 2018-04-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.